Home › Companies › EDITAS MEDICINE INC. › 2023-2024

EDITAS MEDICINE INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and EDITAS MEDICINE INC.’s Form 8-K, filed 2024-05-31 (Item 5.07 on EDGAR). Page generated 04 October 2026.

6Reported items
290Asset managers
1,285Fund votes
2024-05-30Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore EDITAS MEDICINE INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by EDITAS MEDICINE INC.

These tallies are EDITAS MEDICINE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-31 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

EDITAS MEDICINE INC. — official shareholder meeting results, meeting held 2024-05-30
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Meeta Chatterjee, Ph.D.	32,769,825	--	--	8,815,678	17,765,319	Majority: yes
Elect Director: Andrew Hirsch	32,759,650	--	--	8,825,853	17,765,319	Majority: yes
Elect Director: Gilmore O'Neill, M.B.	32,909,172	--	--	8,676,331	17,765,319	Majority: yes
Proposal 2: The Company's stockholders approved, on an advisory basis, the compensation paid to its named executive officers.	38,609,828	2,769,887	205,788	--	17,765,319	Passed
Proposal 3: The Company's stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year.	57,952,408	362,117	1,036,297	--	0	Majority: yes

Source: EDITAS MEDICINE INC., Form 8-K, filed with the SEC on 2024-05-31 — read the filing on EDGAR.

How asset managers voted at the EDITAS MEDICINE INC. 2023-2024 meeting

Each item below shows how the 290 asset managers that disclosed a EDITAS MEDICINE INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of EDITAS MEDICINE INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on an advisory basis, the compensation paid to the Company's named executive officers.

COMPENSATIONCompany result: Passed

Combines 17 wordings of this item as funds reported it.

93% Passed · of votes cast

FOR 93%

FOR: 38,609,828AGAINST: 2,769,887

EDITAS MEDICINE INC.’s own tally for this item (“Proposal 2: The Company's stockholders approved, on an advisory basis, the compensation paid to its named executive officers.”): 38,609,828 for, 2,769,887 against — passed, per its Form 8-K filed 2024-05-31 (Item 5.07). Of all 82,234,951 outstanding shares: 47.0% for, 3% against (50.3% of the company cast a for/against vote).

The 282 asset managers below cast 96% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 96%

FOR: 96.3%AGAINST: 3.6%ABSTAIN: 0.0%NOT VOTED: 0.0%

Largest asset managers voting on “To approve, on an advisory basis, the compensation paid to the Company's named executive officers.” at EDITAS MEDICINE INC., 2023-2024
Asset manager	For	Against	Vote
State Street	13,210,897	0	For
Vanguard	8,555,597	0	For
BlackRock	4,305,099	0	For
Dimensional	1,975,861	0	For
Deep Track Capital, LP	1,920,429	0	For
Charles Schwab	1,712,190	0	For
PICTET ASSET MANAGEMENT SA	1,126,151	0	For
Nuveen	1,020,434	0	For
TIAA	1,003,872	0	For
JPMorgan	946,174	0	For
Woodline Partners LP	895,000	0	For
UBS	3,287	700,266	Against
MARSHALL WACE, LLP	0	693,855	Against
Goldman Sachs	673,333	0	For
Direxion Shares ETF Trust	633,402	0	For
Rafferty Asset Management, LLC	633,402	0	For
Northern Trust	508,277	2,878	For
DE Shaw	476,805	0	For
Neuberger Berman	413,278	0	For
GEODE CAPITAL MANAGEMENT, LLC	343,763	0	For
Fidelity	328,340	0	For
SEI	320,010	0	For
STIFEL NICOLAUS & CO INC \MO\	247,121	0	For
American Century	222,304	0	For
Equitable	206,037	0	For

Showing the 25 largest of 282 asset managers. See all 282 in the interactive database.

2. TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%

FOR: 57,952,408AGAINST: 362,117

EDITAS MEDICINE INC.’s own tally for this item (“Proposal 3: The Company's stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year.”): 57,952,408 for, 362,117 against, per its Form 8-K filed 2024-05-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 82,234,951 outstanding shares: 70% for, 0.5% against (71% of the company cast a for/against vote).

The 60 asset managers below cast 99.9% of the shares they voted on this item FOR (22,990,189 for, 9,916 against).

FOR 99.8%

FOR: 22,990,189 (99.9%)AGAINST: 9,916 (0.0%)ABSTAIN: 20,268 (0.1%)

Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ” at EDITAS MEDICINE INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	8,440,666	0	For
State Street	5,829,081	9,916	For
BlackRock	1,799,371	0	For
Dimensional	1,668,990	0	For
TIAA	1,003,672	0	For
Charles Schwab	856,095	0	For
Direxion Shares ETF Trust	633,402	0	For
Goldman Sachs	520,168	0	For
Fidelity	293,368	0	For
Equitable	206,037	0	For
Global X	185,398	0	For
SEI	158,118	0	For
ProShares	145,221	0	For
Neuberger Berman	137,826	0	For
QUANTITATIVE MASTER SERIES LLC	125,434	0	For
American Century	111,152	0	For
Jackson National	91,678	0	For
Investment Managers Series Trust II	89,803	0	For
Northern Trust	79,337	0	For
Victory Capital	78,471	0	For
Lincoln Financial	74,931	0	For
Bridge Builder Trust	57,505	0	For
AIG/SunAmerica	40,870	0	For
Pacific Life	32,318	0	For
Listed Funds Trust	31,670	0	For

Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.

3. Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Andrew Hirsch

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%WITHHELD 21%

FOR: 32,759,650WITHHELD: 8,825,853

EDITAS MEDICINE INC.’s own tally for this item (“Elect Director: Andrew Hirsch”): 32,759,650 for, 8,825,853 withheld, per its Form 8-K filed 2024-05-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 82,234,951 outstanding shares: 40% for, 11% withheld (50.6% of the company cast a for/withheld vote).

The 57 asset managers below cast 100% of the shares they voted on this item FOR (19,301,339 for, 0 against).

FOR 84%ABSTAIN 16%

FOR: 19,301,339 (84.2%)ABSTAIN: 3,628,001 (15.8%)

Largest asset managers voting on “Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Andrew Hirs” at EDITAS MEDICINE INC., 2023-2024
Asset manager	For	Abstain	Vote
Vanguard	8,440,666	0	For
State Street	5,754,847	84,150	For
BlackRock	1,799,371	0	For
Dimensional	0	1,668,990	Abstain
TIAA	1,003,672	0	For
Charles Schwab	856,095	0	For
Direxion Shares ETF Trust	0	633,402	Abstain
Goldman Sachs	0	520,168	Abstain
Fidelity	293,368	0	For
Equitable	124,737	81,300	For
Global X	185,398	0	For
SEI	158,118	0	For
ProShares	0	145,221	Abstain
Neuberger Berman	137,826	0	For
QUANTITATIVE MASTER SERIES LLC	125,434	0	For
American Century	0	111,152	Abstain
Jackson National	71,043	20,635	For
Northern Trust	79,337	0	For
Victory Capital	0	78,471	Abstain
Lincoln Financial	70,938	3,993	For
Bridge Builder Trust	33,545	23,960	For
AIG/SunAmerica	0	40,870	Abstain
Pacific Life	32,318	0	For
Listed Funds Trust	0	31,670	Abstain
Prudential/PGIM	31,295	0	For

Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.

4. Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Gilmore O'Neill, M.B.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%WITHHELD 21%

FOR: 32,909,172WITHHELD: 8,676,331

EDITAS MEDICINE INC.’s own tally for this item (“Elect Director: Gilmore O'Neill, M.B.”): 32,909,172 for, 8,676,331 withheld, per its Form 8-K filed 2024-05-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 82,234,951 outstanding shares: 40% for, 11% withheld (50.6% of the company cast a for/withheld vote).

The 57 asset managers below cast 100% of the shares they voted on this item FOR (19,382,639 for, 0 against).

FOR 85%ABSTAIN 15%

FOR: 19,382,639 (84.5%)ABSTAIN: 3,546,701 (15.5%)

Largest asset managers voting on “Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Gilmore O'N” at EDITAS MEDICINE INC., 2023-2024
Asset manager	For	Abstain	Vote
Vanguard	8,440,666	0	For
State Street	5,754,847	84,150	For
BlackRock	1,799,371	0	For
Dimensional	0	1,668,990	Abstain
TIAA	1,003,672	0	For
Charles Schwab	856,095	0	For
Direxion Shares ETF Trust	0	633,402	Abstain
Goldman Sachs	0	520,168	Abstain
Fidelity	293,368	0	For
Equitable	206,037	0	For
Global X	185,398	0	For
SEI	158,118	0	For
ProShares	0	145,221	Abstain
Neuberger Berman	137,826	0	For
QUANTITATIVE MASTER SERIES LLC	125,434	0	For
American Century	0	111,152	Abstain
Jackson National	71,043	20,635	For
Northern Trust	79,337	0	For
Victory Capital	0	78,471	Abstain
Lincoln Financial	70,938	3,993	For
Bridge Builder Trust	33,545	23,960	For
AIG/SunAmerica	0	40,870	Abstain
Pacific Life	32,318	0	For
Listed Funds Trust	0	31,670	Abstain
Prudential/PGIM	31,295	0	For

Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.

5. Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Meeta Chatterjee, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%WITHHELD 21%

FOR: 32,769,825WITHHELD: 8,815,678

EDITAS MEDICINE INC.’s own tally for this item (“Elect Director: Meeta Chatterjee, Ph.D.”): 32,769,825 for, 8,815,678 withheld, per its Form 8-K filed 2024-05-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 82,234,951 outstanding shares: 40% for, 11% withheld (50.6% of the company cast a for/withheld vote).

The 57 asset managers below cast 100% of the shares they voted on this item FOR (19,301,339 for, 0 against).

FOR 84%ABSTAIN 16%

FOR: 19,301,339 (84.2%)ABSTAIN: 3,628,001 (15.8%)

Largest asset managers voting on “Election of three Class II Directors, each to serve until the 2027 Annual Meeting of Stockholders: Meeta Chatt” at EDITAS MEDICINE INC., 2023-2024
Asset manager	For	Abstain	Vote
Vanguard	8,440,666	0	For
State Street	5,754,847	84,150	For
BlackRock	1,799,371	0	For
Dimensional	0	1,668,990	Abstain
TIAA	1,003,672	0	For
Charles Schwab	856,095	0	For
Direxion Shares ETF Trust	0	633,402	Abstain
Goldman Sachs	0	520,168	Abstain
Fidelity	293,368	0	For
Equitable	124,737	81,300	For
Global X	185,398	0	For
SEI	158,118	0	For
ProShares	0	145,221	Abstain
Neuberger Berman	137,826	0	For
QUANTITATIVE MASTER SERIES LLC	125,434	0	For
American Century	0	111,152	Abstain
Jackson National	71,043	20,635	For
Northern Trust	79,337	0	For
Victory Capital	0	78,471	Abstain
Lincoln Financial	70,938	3,993	For
Bridge Builder Trust	33,545	23,960	For
AIG/SunAmerica	0	40,870	Abstain
Pacific Life	32,318	0	For
Listed Funds Trust	0	31,670	Abstain
Prudential/PGIM	31,295	0	For

Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.

6. DIRECTOR

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 34%UNKNOWN 66%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (3,650 for, 0 against).

FOR: 3,650 (33.9%)UNKNOWN: 7,123 (66.1%)

Largest asset managers voting on “DIRECTOR” at EDITAS MEDICINE INC., 2023-2024
Asset manager	For	Vote
QP WEALTH MANAGEMENT, LLC	0	Unknown
RBB FUND, INC.	3,630	For
apricus wealth, LLC	20	For

Largest EDITAS MEDICINE INC. shareholders voting in 2023-2024

Ranked by the number of EDITAS MEDICINE INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 82,234,951 shares outstanding at the time of that meeting.

Top EDITAS MEDICINE INC. shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	State Street	16.06%
2	Vanguard	10.40%
3	BlackRock	5.24%
4	Dimensional	2.40%
5	Deep Track Capital, LP	2.34%
6	Charles Schwab	2.11%
7	PICTET ASSET MANAGEMENT SA	1.37%
8	Nuveen	1.24%
9	TIAA	1.22%
10	JPMorgan	1.15%

Reported EDITAS MEDICINE INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

EDITAS MEDICINE INC. beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
State Street	10.65%	13F
BlackRock	9.75%	13F
Vanguard Group	8.47%	13F
Deep Track Capital, LP	6.66%	DEF14A
Dimensional Fund Advisors	3.17%	13F
Millennium Management	2.72%	13F
Geode Capital	2.36%	13F
Two Sigma	1.69%	13F
D.E. Shaw	1.32%	13F
Morgan Stanley	1.32%	13F

Percentages above are of 82,234,951 shares outstanding, as reported by EDITAS MEDICINE INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from EDITAS MEDICINE INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At EDITAS MEDICINE INC.'s shareholder meeting held 2024-05-30, in the 2023-2024 proxy season, 290 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,285 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation paid to the Company's named executive… — the proposal passed with 93% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: EDITAS MEDICINE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-31.

EDITAS MEDICINE INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.